Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.8%

2 terminated/withdrawn out of 17 trials

Success Rate

81.8%

-4.7% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
6(54.5%)
Phase 1
2(18.2%)
Phase 2
2(18.2%)
Phase 4
1(9.1%)
11Total
N/A(6)
Phase 1(2)
Phase 2(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT07546188Recruiting

AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

Role: lead

NCT06718348Not ApplicableRecruiting

Assessing the Japet.W+ Lumbar Traction Device in Rehabilitation for Patients With Non-specific Mechanical Low Back Pain

Role: lead

NCT06569771Recruiting

Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation

Role: lead

NCT07213128Not ApplicableRecruiting

Effect of IMT in Patients After Acute Exacerbations of COPD

Role: collaborator

NCT06241729Recruiting

Prospective Observational Study of Diffuse Large-cell B Lymphoma

Role: lead

NCT06333106Not ApplicableCompleted

PoCUS Diagnostic Accuracy for Fecal Impaction in the Emergency Department: A Prospective Study

Role: collaborator

NCT03127007Phase 1Completed

Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer

Role: lead

NCT04436250Not ApplicableTerminated

ESKETamine for FIBromyalgia Treatment

Role: lead

NCT03356860Phase 1Completed

Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.

Role: lead

NCT05951881Completed

Comparative Study of the Performance of Drug Anamneses in an Emergency Department

Role: lead

NCT05620953Completed

Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)

Role: collaborator

NCT05729230Completed

PAtient-PHYsician Relationship Assessment

Role: collaborator

NCT03476109Phase 4Unknown

Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.

Role: collaborator

NCT04813497Not ApplicableCompleted

Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members

Role: lead

NCT04723290Not ApplicableCompleted

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Role: lead

NCT01858649Phase 2Completed

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.

Role: collaborator

NCT01858662Phase 2Terminated

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

Role: collaborator

All 17 trials loaded